Myeloid microvesicles are a marker and therapeutic target for neuroinflammation

Annals of Neurology

Volumn 72, Issue 4, 2012, Pages 610-624

  Verderio, Claudia ^a   Muzio, Luca ^b   Turola, Elena ^a   Bergami, Alessandra ^b   Novellino, Luisa ^a   Ruffini, Francesca ^b   Riganti, Loredana ^a   Corradini, Irene ^a   Francolini, Maura ^a   Garzetti, Livia ^b   Maiorino, Chiara ^b   Servida, Federica ^a   Vercelli, Alessandro ^c   Rocca, Mara ^b   Libera, Dacia Dalla ^b   Martinelli, Vittorio ^b   Comi, Giancarlo ^b   Martino, Gianvito ^b   Matteoli, Michela ^a,d   Furlan, Roberto ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; BIOLOGICAL MARKER; CD206 ANTIGEN; CD86 ANTIGEN; CYCLOOXYGENASE 2; FINGOLIMOD; GLIAL FIBRILLARY ACIDIC PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CELL COMMUNICATION; CEREBROSPINAL FLUID; CONTROLLED STUDY; DISEASE ACTIVITY; ELECTRON MICROSCOPY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; IN VIVO STUDY; MACROPHAGE; MAJOR CLINICAL STUDY; MEMBRANE VESICLE; MICROGLIA; MOUSE; MULTIPLE SCLEROSIS; MYELOID MICROVESICLE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; TISSUE INJURY;

ANIMALS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CALCIUM SIGNALING; CELL COMMUNICATION; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM DISEASES; ENCEPHALITIS; FLOW CYTOMETRY; INFLAMMATION; LENTIVIRUS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, ELECTRON; MICROSCOPY, FLUORESCENCE; MULTIPLE SCLEROSIS; NERVOUS SYSTEM AUTOIMMUNE DISEASE, EXPERIMENTAL; NEUROGLIA; RATS; RATS, INBRED LEW; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; SPHINGOMYELIN PHOSPHODIESTERASE; SPINAL CORD;

EID: 84866343704     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.23627     Document Type: Article

References (55)

1. Al-Nedawi K, Meehan B, Rak J,. Microvesicles: messengers and mediators of tumor progression. Cell Cycle 2009; 8: 2014-2018.
2. Cocucci E, Racchetti G, Meldolesi J,. Shedding microvesicles: artefacts no more. Trends Cell Biol 2009; 19: 43-51.
3. Ratajczak J, Wysoczynski M, Hayek F, et al. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 2006; 20: 1487-1495.
4. Thery C, Ostrowski M, Segura E,. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 2009; 9: 581-593.
5. Bianco F, Perrotta C, Novellino L, et al. Acid sphingomyelinase activity triggers microparticle release from glial cells. EMBO J 2009; 28: 1043-1054.
6. Bernimoulin M, Waters EK, Foy M, et al. Differential stimulation of monocytic cells results in distinct populations of microparticles. J Thromb Haemost 2009; 7: 1019-1028.
7. van der Vos KE, Balaj L, Skog J, Breakefield XO,. Brain tumor microvesicles: insights into intercellular communication in the nervous system. Cell Mol Neurobiol 2011; 31: 949-959.
8. Doeuvre L, Plawinski L, Toti F, Angles-Cano E,. Cell-derived microparticles: a new challenge in neuroscience. J Neurochem 2009; 110: 457-468.
9. Emmanouilidou E, Melachroinou K, Roumeliotis T, et al. Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J Neurosci 2010; 30: 6838-6851.
10. Gyorgy B, Szabo TG, Pasztoi M, et al. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci 2011; 68: 2667-2688.
11. Bakhti M, Winter C, Simons M,. Inhibition of myelin membrane sheath formation by oligodendrocyte-derived exosome-like vesicles. J Biol Chem 2011; 286: 787-796.
12. Court FA, Midha R, Cisterna BA, et al. Morphological evidence for a transport of ribosomes from Schwann cells to regenerating axons. Glia 2011; 59: 1529-1539.
13. Ardoin SP, Pisetsky DS,. The role of cell death in the pathogenesis of autoimmune disease: HMGB1 and microparticles as intercellular mediators of inflammation. Mod Rheumatol 2008; 18: 319-326.
14. Vella LJ, Sharples RA, Lawson VA, et al. Packaging of prions into exosomes is associated with a novel pathway of PrP processing. J Pathol 2007; 211: 582-590.
15. Al-Nedawi K, Meehan B, Micallef J, et al. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Biol 2008; 10: 619-624.
16. Bianco F, Pravettoni E, Colombo A, et al. Astrocyte-derived ATP induces vesicle shedding and IL-1 beta release from microglia. J Immunol 2005; 174: 7268-7277.
17. Graeber MB, Li W, Rodriguez M,. Role of microglia in CNS inflammation. FEBS Lett 2011; 585: 3798-3805.
18. Scolding NJ, Morgan BP, Houston WA, et al. Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement. Nature 1989; 339: 620-622.
19. Ponomarev ED, Veremeyko T, Barteneva N, et al. MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-alpha-PU.1 pathway. Nat Med 2011; 17: 64-70.
20. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69: 292-302.
21. Horinouchi K, Erlich S, Perl DP, et al. Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease. Nat Genet 1995; 10: 288-293.
22. Jung S, Aliberti J, Graemmel P, et al. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol 2000; 20: 4106-4114.
23. Ayoub AE, Salm AK,. Increased morphological diversity of microglia in the activated hypothalamic supraoptic nucleus. J Neurosci 2003; 23: 7759-7766.
24. Muzio L, Cavasinni F, Marinaro C, et al. Cxcl10 enhances blood cells migration in the sub-ventricular zone of mice affected by experimental autoimmune encephalomyelitis. Mol Cell Neurosci 2010; 43: 268-280.
25. Otterbach B, Stoffel W,. Acid sphingomyelinase-deficient mice mimic the neurovisceral form of human lysosomal storage disease (Niemann-Pick disease). Cell 1995; 81: 1053-1061.
26. Furlan R, Cuomo C, Martino G,. Animal models of multiple sclerosis. Methods Mol Biol 2009; 549: 157-173.
27. Prinz M, Mildner A,. Microglia in the CNS: immigrants from another world. Glia 2011; 59: 177-187.
28. Qu Y, Ramachandra L, Mohr S, et al. P2X7 receptor-stimulated secretion of MHC class II-containing exosomes requires the ASC/NLRP3 inflammasome but is independent of caspase-1. J Immunol 2009; 182: 5052-5062.
29. Sarkar A, Mitra S, Mehta S, et al. Monocyte derived microvesicles deliver a cell death message via encapsulated caspase-1. PLoS One 2009; 4: e7140.
30. Engelhardt B, Wolburg-Buchholz K, Wolburg H,. Involvement of the choroid plexus in central nervous system inflammation. Microsc Res Tech 2001; 52: 112-129.
31. Kivisakk P, Imitola J, Rasmussen S, et al. Localizing central nervous system immune surveillance: meningeal antigen-presenting cells activate T cells during experimental autoimmune encephalomyelitis. Ann Neurol 2009; 65: 457-469.
32. Hemmer B, Archelos JJ, Hartung HP,. New concepts in the immunopathogenesis of multiple sclerosis. Nat Rev Neurosci 2002; 3: 291-301.
33. Colton CA, Mott RT, Sharpe H, et al. Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J Neuroinflammation 2006; 3: 27.
34. Mantovani A, Sica A, Sozzani S, et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004; 25: 677-686.
35. Michelucci A, Heurtaux T, Grandbarbe L, et al. Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: effects of oligomeric and fibrillar amyloid-beta. J Neuroimmunol 2009; 210: 3-12.
36. Pluchino S, Muzio L, Imitola J, et al. Persistent inflammation alters the function of the endogenous brain stem cell compartment. Brain 2008; 131: 2564-2578.
37. Politi LS, Bacigaluppi M, Brambilla E, et al. Magnetic-resonance-based tracking and quantification of intravenously injected neural stem cell accumulation in the brains of mice with experimental multiple sclerosis. Stem Cells 2007; 25: 2583-2592.
38. Antonucci F, Turola E, Riganti L, et al. Microvesicles released from microglia stimulate synaptic activity via enhanced sphingolipid metabolism. EMBO J 2012; 31: 1231-1240.
39. Dawson G, Qin J,. Gilenya (FTY720) inhibits acid sphingomyelinase by a mechanism similar to tricyclic antidepressants. Biochem Biophys Res Commun 2011; 404: 321-323.
40. Cohen JA, Chun J,. Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis. Ann Neurol 2011; 69: 759-777.
41. Ransohoff RM, Cardona AE,. The myeloid cells of the central nervous system parenchyma. Nature 2010; 468: 253-262.
42. MacKenzie A, Wilson HL, Kiss-Toth E, et al. Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity 2001; 15: 825-835.
43. Pizzirani C, Ferrari D, Chiozzi P, et al. Stimulation of P2 receptors causes release of IL-1beta-loaded microvesicles from human dendritic cells. Blood 2007; 109: 3856-3864.
44. Centonze D, Muzio L, Rossi S, et al. Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis. J Neurosci 2009; 29: 3442-3452.
45. Faure J, Lachenal G, Court M, et al. Exosomes are released by cultured cortical neurones. Mol Cell Neurosci 2006; 31: 642-648.
46. Taylor AR, Robinson MB, Gifondorwa DJ, et al. Regulation of heat shock protein 70 release in astrocytes: role of signaling kinases. Dev Neurobiol 2007; 67: 1815-1829.
47. Ostrowski M, Carmo NB, Krumeich S, et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol 2010; 12: 19-30; sup pp 11-13.
48. Schwartz M, Shechter R,. Systemic inflammatory cells fight off neurodegenerative disease. Nature reviews. Neurology 2010; 6: 405-410.
49. Biswas SK, Mantovani A,. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 2010; 11: 889-896.
50. Centonze D, Muzio L, Rossi S, et al. The link between inflammation, synaptic transmission and neurodegeneration in multiple sclerosis. Cell Death Differ 2009; 17: 1083-1091.
51. Thomas LM, Salter RD,. Activation of macrophages by P2X7-induced microvesicles from myeloid cells is mediated by phospholipids and is partially dependent on TLR4. J Immunol 2010; 185: 3740-3749.
52. Matute C, Torre I, Perez-Cerda F, et al. P2X(7) receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis. J Neurosci 2007; 27: 9525-9533.
53. Sharp AJ, Polak PE, Simonini V, et al. P2x7 deficiency suppresses development of experimental autoimmune encephalomyelitis. J Neuroinflammation 2008; 5: 33.
54. Kappos L, Antel J, Comi G, et al. Oral fingolimod (FTY720) for relapsing multiple sclerosis. N Engl J Med 2006; 355: 1124-1140.
55. Fujino M, Funeshima N, Kitazawa Y, et al. Amelioration of experimental autoimmune encephalomyelitis in Lewis rats by FTY720 treatment. J Pharmacol Exp Ther 2003; 305: 70-77.